FDA approves Blueprint's stomach cancer therapy priced at $32,000 per month

The U.S. Food and Drug Administration approved Blueprint Medicines Corp's oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday.

from Reuters: Health News https://ift.tt/30gTLgd
via IFTTT